Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2019
Same author

Aligning the many definitions of treatment resistance in anxiety disorders: A systematic review.

Depression and anxiety·2019
Same author

Measuring social support in psychiatric patients and controls: Validation and reliability of the shortened Close Persons Questionnaire.

Journal of psychiatric research·2019
Same author

GWAS of Suicide Attempt in Psychiatric Disorders and Association With Major Depression Polygenic Risk Scores.

The American journal of psychiatry·2019
Same author

Accelerating research on biological aging and mental health: Current challenges and future directions.

Psychoneuroendocrinology·2019
Same author

A catalog of genetic loci associated with kidney function from analyses of a million individuals.

Nature genetics·2019
Same journal

From Target Engagement to Treatment Governance: The Evolving Role of Amyloid PET in Anti-Amyloid Therapy.

The Lancet regional health. Europe·2026
Same journal

Preparing Europe for Recurrent Autochthonous Dengue Transmission: Public Health Implications and Preparedness Priorities.

The Lancet regional health. Europe·2026
Same journal

Towards HPV-Based Cervical Cancer Screening in Poland: Lessons From a Landmark Trial.

The Lancet regional health. Europe·2026
Same journal

Andes Virus on a Cruise Ship, what it Tells us About the Global Pandemic Preparedness Agenda.

The Lancet regional health. Europe·2026
Same journal

Early impact of RSV prevention on infant hospitalisations in Denmark.

The Lancet regional health. Europe·2026
Same journal

Quantifying the potential of alcohol policies for cancer prevention in the EU: a modelling study.

The Lancet regional health. Europe·2026
See all related articles

Related Experiment Video

Updated: Jun 3, 2025

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice
05:28

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

Published on: May 15, 2019

22.0K

Immuno-metabolic depression: from concept to implementation.

Brenda W J H Penninx1, Femke Lamers1, Rick Jansen1

  • 1Department of Psychiatry, Amsterdam Public Health and Amsterdam Neuroscience, Amsterdam UMC, Vrije University, Amsterdam, the Netherlands.

The Lancet Regional Health. Europe
|January 13, 2025
PubMed
Summary
This summary is machine-generated.

A subtype of depression, immuno-metabolic depression, affects 20-30% of patients and involves inflammation and metabolic issues. Targeting these factors may improve treatment outcomes for this specific depression subtype.

Keywords:
DepressionDyslipidaemiaInflammationMetabolic alterationsNeurobiologyPrecision psychiatry

More Related Videos

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

449
Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

14.5K

Related Experiment Videos

Last Updated: Jun 3, 2025

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice
05:28

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

Published on: May 15, 2019

22.0K
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

449
Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

14.5K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Immunology
  • Metabolic Science

Background:

  • Major depressive disorder (MDD) presents significant heterogeneity, complicating effective treatment strategies.
  • Understanding the biological underpinnings of depression subtypes is crucial for developing personalized interventions.
  • A notable subset of individuals with depression exhibits immuno-metabolic dysregulations.

Purpose of the Study:

  • To review the concept of immuno-metabolic depression.
  • To highlight the prevalence and characteristics of this depression subtype.
  • To discuss potential treatment avenues aligned with precision psychiatry.

Main Methods:

  • Literature review focusing on immuno-metabolic dysregulations in depression.
  • Analysis of the clustering of specific depressive symptoms, inflammatory markers, and metabolic abnormalities.
  • Examination of the association between immuno-metabolic depression and cardiometabolic disease risk.

Main Results:

  • Immuno-metabolic dysregulations are identified in 20-30% of individuals with depression.
  • This subtype is characterized by atypical depressive symptoms (hypersomnia, fatigue, hyperphagia), low-grade systemic inflammation, and metabolic abnormalities (obesity, insulin resistance).
  • Individuals with immuno-metabolic depression face increased risk for cardiometabolic diseases and show poorer response to standard antidepressants.

Conclusions:

  • Immuno-metabolic depression represents a distinct subtype of MDD with specific biological markers.
  • Targeted interventions addressing inflammation, metabolism, and lifestyle factors show promise for this patient group.
  • Precision psychiatry principles can guide more effective treatment selection for immuno-metabolic depression.